Lisata Therapeutics EPS LSTA

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Lisata Therapeutics' earnings per share was −$1.65 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.32.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.32	n/a	−$1.65
Q1 FY26	Mar 31, 2026	−$0.50	n/a	−$1.87
Q4 FY25	Dec 31, 2025	−$0.34	n/a	−$1.92
Q3 FY25	Sep 30, 2025	−$0.49	n/a	−$2.13
Q2 FY25	Jun 30, 2025	−$0.54	n/a	−$2.23
Q1 FY25	Mar 31, 2025	−$0.55	n/a	−$2.30
Q4 FY24	Dec 31, 2024	−$0.55	n/a	−$2.40
Q3 FY24	Sep 30, 2024	−$0.59	n/a	−$2.51
Q2 FY24	Jun 30, 2024	−$0.61	n/a	−$2.57
Q1 FY24	Mar 31, 2024	−$0.65	n/a	−$2.46
Q4 FY23	Dec 31, 2023	−$0.66	n/a	−$2.58
Q3 FY23	Sep 30, 2023	−$0.65	n/a	−$2.68

Companies in Drug Manufacturers - General nearest Lisata Therapeutics' size, closest first, today.

Company	EPS, 12 months	Growth
LSTALisata Therapeutics	−$1.65
ATNMActinium Pharmaceuticals	$0.36
SPROSpero Therapeutics	$0.11
LFVNLifevantage	$0.40	−46% a year
Peer median	$0.36

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.